Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Onconova Therapeutics Inc...

    NASDAQ: ONTX · Real-Time Price · USD
    1.00
    0.00 (0.00%)
    At close: Apr 02, 2024, 10:00 PM

    Onconova Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 226B 226K 226K 226K
    Cost of Revenue
    		 117,464B -226B 14K 14K
    Gross Profit
    		 -117,238B 226B 212K 212K
    Operating Income
    		 -142,374B -20.3M -19.63M -16.5M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -166,523B -18.95M -18.96M -16.16M
    Net Income
    		 -166,523B -18.95M -18.3M -15.83M
    Selling & General & Admin
    		 12,289B 9.09M 8.45M 9.43M
    Research & Development
    		 12,847B 11.43M 11.41M 7.3M
    Other Expenses
    		 n/a 1.35M n/a 12K
    Operating Expenses
    		 25,136B 20.52M 19.85M 16.72M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 142,600B 20.52M 19.85M 16.72M
    Income Tax Expense
    		 n/a n/a -663K -335K
    Shares Outstanding (Basic)
    		 15.53M 20.99M 20.91M 16.83M
    Shares Outstanding (Diluted)
    		 15.53M 20.99M 20.91M 16.83M
    EPS (Basic)
    		 -10.72M -0.9 -0.88 -0.94
    EPS (Diluted)
    		 -10.72M -0.9 -0.88 -0.94
    EBITDA
    		 -142,374B -20.28M -19.63M -16.82M
    EBIT
    		 n/a -20.3M -18.98M -16.5M
    Depreciation & Amortization
    		 n/a 16K 14K -321K

    Add to Watchlist